225 related articles for article (PubMed ID: 2191313)
21. Recurrent nephrotic syndrome after living-related renal transplantation resistant to plasma exchange: report of two cases.
Masutani K; Katafuchi R; Ikeda H; Yamamoto H; Motoyama K; Sugitani A; Kanai H; Kumagai H; Hirakata H; Tanaka M; Iida M
Clin Transplant; 2005; 19 Suppl 14():59-64. PubMed ID: 15955171
[TBL] [Abstract][Full Text] [Related]
22. A combined low-density lipoprotein apheresis and prednisone therapy for steroid-resistant primary focal segmental glomerulosclerosis in children.
Hattori M; Chikamoto H; Akioka Y; Nakakura H; Ogino D; Matsunaga A; Fukazawa A; Miyakawa S; Khono M; Kawaguchi H; Ito K
Am J Kidney Dis; 2003 Dec; 42(6):1121-30. PubMed ID: 14655182
[TBL] [Abstract][Full Text] [Related]
23. In vitro and in vivo studies with different precipitate filter cartridges for H.E.L.P.-LDL-apheresis. Optimization of precipitate filter cartridges.
Morsch G; Maywald F; Wanner C
Bioseparation; 1995 Feb; 5(1):11-8. PubMed ID: 7766149
[TBL] [Abstract][Full Text] [Related]
24. Low density lipoprotein apheresis therapy for steroid-resistant nephrotic syndrome. Kansai-FGS-Apheresis Treatment (K-FLAT) Study Group.
Muso E; Mune M; Fujii Y; Imai E; Ueda N; Hatta K; Imada A; Miki S; Kuwahara T; Takamitsu Y; Takemura T; Tsubakihara Y
Kidney Int Suppl; 1999 Jul; 71():S122-5. PubMed ID: 10412754
[TBL] [Abstract][Full Text] [Related]
25. Advances in apheresis therapy for glomerular diseases.
Yokoyama H; Wada T; Zhang W; Yamaya H; Asaka M
Clin Exp Nephrol; 2007 Jun; 11(2):122-127. PubMed ID: 17593511
[TBL] [Abstract][Full Text] [Related]
26. Beneficial effect of LDL-apheresis in refractory nephrotic syndrome.
Muso E
Clin Exp Nephrol; 2014 Apr; 18(2):286-90. PubMed ID: 24535024
[TBL] [Abstract][Full Text] [Related]
27. [Therapeutic apheresis in idiopathic nephrotic syndrome].
Moriconi L
G Ital Nefrol; 2012; 29 Suppl 54():S67-72. PubMed ID: 22388834
[TBL] [Abstract][Full Text] [Related]
28. [Therapeutic advances in glomerular nephropathies].
Pérez García R
Rev Clin Esp; 1991 Nov; 189(7):305-8. PubMed ID: 1767085
[No Abstract] [Full Text] [Related]
29. Effect of post-transplant double filtration plasmapheresis on recurrent focal and segmental glomerulosclerosis in renal transplant recipients.
Otsubo S; Tanabe K; Shinmura H; Ishikawa N; Tokumoto T; Hattori M; Ito K; Nitta K; Akiba T; Nihei H; Toma H
Ther Apher Dial; 2004 Aug; 8(4):299-304. PubMed ID: 15274681
[TBL] [Abstract][Full Text] [Related]
30. Effect of low-density lipoprotein-apheresis on nephrotic syndrome due to membranous nephropathy in renal allograft: a case report.
Ideura T; Hora K; Kaneko Y; Yamazaki T; Tokunaga S; Shigematsu H; Kiyosawa K
Transplant Proc; 2000 Feb; 32(1):223-6. PubMed ID: 10701029
[No Abstract] [Full Text] [Related]
31. Umbilical Cord Blood Transplantation-associated Nephrotic Syndrome Successfully Treated by Low-density Lipoprotein Apheresis.
Sugawara Y; Honda K; Katagiri D; Nakamura M; Kawakami T; Nasu R; Hayashi A; Shintani Y; Tojo A; Noiri E; Kurokawa M; Fukayama M; Nangaku M
Intern Med; 2016; 55(19):2831-2836. PubMed ID: 27725544
[TBL] [Abstract][Full Text] [Related]
32. [Nephrotic syndrome and LDL apheresis].
Muso E
Nihon Jinzo Gakkai Shi; 2013; 55(7):1301-13. PubMed ID: 24288967
[No Abstract] [Full Text] [Related]
33. Increased urinary protein excretion in the rat produced by serum from a patient with recurrent focal glomerular sclerosis after renal transplantation.
Zimmerman SW
Clin Nephrol; 1984 Jul; 22(1):32-8. PubMed ID: 6383672
[TBL] [Abstract][Full Text] [Related]
34. Low-density lipoprotein apheresis for focal glomerular sclerosis.
Yorioka N; Taniguchi Y; Nishida Y; Okushin S; Amimoto D; Yamakido M
Ther Apher; 1997 Nov; 1(4):370-1. PubMed ID: 10225734
[TBL] [Abstract][Full Text] [Related]
35. Liposorber® LA-15 system for LDL apheresis in resistant nephrotic syndrome patients.
Al-Mousily M; Nicoara O; Selewski DT; Twombley K
Pediatr Nephrol; 2022 Mar; 37(3):585-592. PubMed ID: 34453196
[TBL] [Abstract][Full Text] [Related]
36. Blood level of cyclosporin [correction of cyclospolin] during LDL-apheresis in nephrotic syndrome patients.
Nakajima F; Shibahara N; Ijiri Y; Ashida A; Ueda H; Katsuoka Y
J Clin Apher; 1999; 14(4):193-4. PubMed ID: 10611632
[No Abstract] [Full Text] [Related]
37. Low-density lipoprotein apheresis for recurrent focal segmental glomerulosclerosis post renal transplant in pediatric patients.
Al-Mousily MF; Nicoara O; Selewski DT; Nadig S; Twombley K
J Clin Apher; 2022 Aug; 37(4):411-414. PubMed ID: 35238425
[TBL] [Abstract][Full Text] [Related]
38. Incidence of nephrotic syndrome in patients with glomerulonephritis.
Sonkodi S; Tichy B; Mágori A; Ormos J
Acta Med Hung; 1986; 43(3):311-3. PubMed ID: 3588169
[TBL] [Abstract][Full Text] [Related]
39. Remission of a refractory nephrotic syndrome after low-density lipoprotein apheresis based on dextrane sulphate adsorption.
Faucher C; Albert C; Beaufils H; Jouanneau C; Dupouet L
Nephrol Dial Transplant; 1997 May; 12(5):1037-9. PubMed ID: 9175066
[No Abstract] [Full Text] [Related]
40. Impact of low-density lipoprotein apheresis for nephrotic syndrome in a patient with immunoglobulin M nephropathy.
Tanaka A; Nakamura T; Sato E; Node K
Nephrology (Carlton); 2016 Dec; 21(12):1073-1074. PubMed ID: 27870230
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
